aTyr Pharma Announces First Quarter 2016 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/26/2026
- Wall St futures fall as chip stocks resume slide after Micron-led rally
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
- Needham Starts NeoVolta (NEOV) at Buy
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- SanDisk stock target lifted by Citi on continued demand strength
aTyr Pharma (LIFE) Tops Q1 EPS by 6c
May 11, 2016 4:02 PM EDTaTyr Pharma (NASDAQ: LIFE) reported Q1 EPS of ($0.68), $0.06 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
... More